Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.071 SGD | +1.43% | +5.97% | +20.34% |
Apr. 12 | Singapore Shares Fall at Market Close; Biolidics Up 9% | MT |
Apr. 12 | Trek 2000 Reports Variances in 2023 Statements | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 25.46 | 16.35 | 24.41 | 23.09 | 17.77 | 14 |
Enterprise Value (EV) 1 | -6.755 | -17.1 | -6.616 | -11.34 | -2.303 | -14.82 |
P/E ratio | -6.92 x | -12.1 x | -19.4 x | -19.2 x | -1.34 x | 5.21 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.85 x | 0.65 x | 0.96 x | 0.62 x | 1.07 x | 0.84 x |
EV / Revenue | -0.22 x | -0.68 x | -0.26 x | -0.3 x | -0.14 x | -0.88 x |
EV / EBITDA | 2.25 x | 5.3 x | 2.05 x | 5.75 x | 0.4 x | 7.43 x |
EV / FCF | 1.16 x | -14.5 x | 1.28 x | -627 x | 0.29 x | -3.61 x |
FCF Yield | 86.3% | -6.91% | 78.4% | -0.16% | 345% | -27.7% |
Price to Book | 0.57 x | 0.4 x | 0.62 x | 0.61 x | 0.68 x | 0.49 x |
Nbr of stocks (in thousands) | 322,027 | 319,453 | 316,002 | 313,092 | 313,092 | 313,092 |
Reference price 2 | 0.0791 | 0.0512 | 0.0772 | 0.0738 | 0.0568 | 0.0447 |
Announcement Date | 4/8/19 | 6/8/20 | 4/13/21 | 4/5/22 | 6/13/23 | 4/11/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 30.08 | 25.05 | 25.37 | 37.34 | 16.62 | 16.76 |
EBITDA 1 | -3.001 | -3.224 | -3.235 | -1.973 | -5.716 | -1.994 |
EBIT 1 | -3.506 | -3.428 | -3.537 | -2.188 | -5.869 | -2.177 |
Operating Margin | -11.65% | -13.69% | -13.94% | -5.86% | -35.32% | -12.99% |
Earnings before Tax (EBT) 1 | -3.116 | -1.285 | -1.288 | -1.184 | -13.31 | 2.711 |
Net income 1 | -3.687 | -1.359 | -1.268 | -1.208 | -13.3 | 2.689 |
Net margin | -12.26% | -5.43% | -5% | -3.24% | -80.03% | 16.04% |
EPS 2 | -0.0114 | -0.004229 | -0.003973 | -0.003850 | -0.0425 | 0.008589 |
Free Cash Flow 1 | -5.831 | 1.181 | -5.186 | 0.0181 | -7.936 | 4.106 |
FCF margin | -19.38% | 4.71% | -20.44% | 0.05% | -47.76% | 24.5% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | 152.69% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/8/19 | 6/8/20 | 4/13/21 | 4/5/22 | 6/13/23 | 4/11/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 32.2 | 33.4 | 31 | 34.4 | 20.1 | 28.8 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -5.83 | 1.18 | -5.19 | 0.02 | -7.94 | 4.11 |
ROE (net income / shareholders' equity) | -7.58% | -3.11% | -3% | -2.99% | -40.5% | 9.59% |
ROA (Net income/ Total Assets) | -3.96% | -4.29% | -4.62% | -3.01% | -9.61% | -4.13% |
Assets 1 | 93.11 | 31.66 | 27.46 | 40.15 | 138.4 | -65.11 |
Book Value Per Share 2 | 0.1400 | 0.1300 | 0.1300 | 0.1200 | 0.0800 | 0.0900 |
Cash Flow per Share 2 | 0.0800 | 0.0500 | 0.0300 | 0.0200 | 0.0100 | 0.0300 |
Capex 1 | 0.02 | 0.12 | 0 | 0.04 | 0.02 | 0.24 |
Capex / Sales | 0.07% | 0.5% | 0.01% | 0.12% | 0.12% | 1.45% |
Announcement Date | 4/8/19 | 6/8/20 | 4/13/21 | 4/5/22 | 6/13/23 | 4/11/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+20.34% | 16.11M | |
+33.40% | 22.81B | |
+16.24% | 21.15B | |
+47.03% | 17.04B | |
+11.93% | 2.39B | |
+11.59% | 782M | |
-5.77% | 798M | |
-7.58% | 438M | |
-28.99% | 340M | |
+3.97% | 257M |
- Stock Market
- Equities
- 5AB Stock
- Financials Trek 2000 International Ltd